Curis (NASDAQ:CRIS – Get Free Report) will post its quarterly earnings results before the market opens on Thursday, August 1st. Analysts expect Curis to post earnings of ($1.70) per share for the quarter.
Curis (NASDAQ:CRIS – Get Free Report) last announced its quarterly earnings results on Tuesday, May 7th. The biotechnology company reported ($2.05) EPS for the quarter, missing the consensus estimate of ($1.94) by ($0.11). The company had revenue of $2.09 million during the quarter, compared to analysts’ expectations of $2.31 million. Curis had a negative net margin of 486.45% and a negative return on equity of 224.75%. During the same quarter in the prior year, the company earned ($2.40) earnings per share. On average, analysts expect Curis to post $-5 EPS for the current fiscal year and $-4 EPS for the next fiscal year.
Curis Price Performance
Shares of NASDAQ:CRIS traded down $0.02 during trading on Friday, hitting $6.00. 7,868 shares of the company were exchanged, compared to its average volume of 32,405. The firm’s 50 day moving average price is $8.23 and its 200-day moving average price is $10.86. Curis has a 12-month low of $3.80 and a 12-month high of $17.49. The stock has a market capitalization of $35.34 million, a P/E ratio of -0.70 and a beta of 3.35.
Analysts Set New Price Targets
View Our Latest Report on CRIS
Curis Company Profile
Curis, Inc, a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule IRAK4 kinase inhibitor, which is in a Phase 1/2 open-label, single arm expansion trial in patients with relapsed or refractory, or R/R, AML and high-risk myelodysplastic syndromes.
Further Reading
- Five stocks we like better than Curis
- What Makes a Stock a Good Dividend Stock?
- 3M Surprises and Rebound Accelerates: It Isn’t Too Late To Get In
- What Is WallStreetBets and What Stocks Are They Targeting?
- Skechers Stock Shows Strength Among Consumer Discretionary Sector
- Stock Analyst Ratings and Canadian Analyst Ratings
- Tech Stocks Tumble, These Stocks Present Buying Opportunity
Receive News & Ratings for Curis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Curis and related companies with MarketBeat.com's FREE daily email newsletter.